Your browser doesn't support javascript.
loading
Molecular and clinical analysis of Chinese patients with anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.
Zhou, Xiaoyun; Shou, Jiawei; Sheng, Jin; Xu, Chunwei; Ren, Shengxiang; Cai, Xiuyu; Chu, Qian; Wang, Wenxian; Zhen, Qinhong; Zhou, Yuefen; Li, Wenfeng; Pan, Hong; Li, Hongsen; Sun, Tao; Cheng, Huanqing; Wang, Huina; Lou, Feng; Rao, Chuangzhou; Cao, Shanbo; Pan, Hongming; Fang, Yong.
Afiliación
  • Zhou X; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
  • Shou J; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
  • Sheng J; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
  • Xu C; Department of Pathology, Fujian Cancer Hospital, Fujian Medical University, Fuzhou, China.
  • Ren S; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Cai X; Sun Yet-Sen University Cancer Center, Guangzhou, China.
  • Chu Q; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wang W; Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, China.
  • Zhen Q; Department of Medical Oncology, Quzhou People's Hospital, Quzhou, China.
  • Zhou Y; Department of Medical Oncology, Lishui Municipal Central Hospital, Lishui, China.
  • Li W; Department of Medical Oncology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Pan H; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
  • Li H; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
  • Sun T; Department of Surgery, University of Chicago, Chicago, USA.
  • Cheng H; Acornmed Biotechnology Co., Ltd., Beijing, China.
  • Wang H; Acornmed Biotechnology Co., Ltd., Beijing, China.
  • Lou F; Acornmed Biotechnology Co., Ltd., Beijing, China.
  • Rao C; Department of Radiation and Chemotherapy, Hwamei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
  • Cao S; Acornmed Biotechnology Co., Ltd., Beijing, China.
  • Pan H; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
  • Fang Y; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
Cancer Sci ; 110(10): 3382-3390, 2019 Oct.
Article en En | MEDLINE | ID: mdl-31444835
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Reordenamiento Génico / Carcinoma de Pulmón de Células no Pequeñas / Pueblo Asiatico / Secuenciación de Nucleótidos de Alto Rendimiento / Quinasa de Linfoma Anaplásico / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2019 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Reordenamiento Génico / Carcinoma de Pulmón de Células no Pequeñas / Pueblo Asiatico / Secuenciación de Nucleótidos de Alto Rendimiento / Quinasa de Linfoma Anaplásico / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2019 Tipo del documento: Article País de afiliación: China